Endocrine Society guidelines serve as a framework for clinical decision making and best practices to optimize patient care. Our guidelines are developed using a robust and rigorous process that adheres to the highest standards of trustworthiness and transparency as defined by the Institute of Medicine. The Endocrine Society’s clinical practice guidelines development program is overseen by the Clinical Guidelines Committee (CGC). This page summarizes the Endocrine Society’s processes for developing evidence-based guidelines.
Enhancing the Trustworthiness of the Endocrine Society’s Clinical Practice Guidelines
Development of Endocrine Society guidelines follows GRADE methodology for the evaluation of evidence and the creation of recommendations. Our guidelines undergo a rigorous review and approval period prior to publication. Read more about our implementation of GRADE and our development process and timelines below.
 |
 |
The Endocrine Society strives to minimize conflicts of interest as it relates to establishing guideline panels and the production of guidelines as much as possible. Read our current conflict of interest policy below.
 |
Funding for the development of guidelines is provided by the Endocrine Society. No other entity provides financial or other support.
